查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1990023

裸金属支架市场：按类型、材质、长度、应用和最终用户划分－2026-2032年全球市场预测

Bare-metal Stents Market by Type, Material, Length, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，裸金属支架市场价值将达到 69.6 亿美元，到 2026 年将成长至 73.3 亿美元，到 2032 年将达到 103.7 亿美元，复合年增长率为 5.84%。

主要市场统计数据
基准年 2025 69.6亿美元
预计年份：2026年 73.3亿美元
预测年份 2032 103.7亿美元
复合年增长率 (%) 5.84%

这篇权威的裸金属支架概述揭示了其在现代介入医学中的临床作用、材料演变和手术重要性。

裸金属支架是介入性血管治疗的基础组成部分，其器械选择、手术操作和材料科学相互交织，共同影响患者的治疗结果。本文概述了裸金属支架目前的技术和临床背景，并阐述了其在特定患者群体和手术情境中的持久作用。儘管药物释放型支架和生物可吸收支架极大地丰富了许多临床医生的选择，但当由于特定病变特征、抗凝血治疗的考虑或成本和手术条件的限製而必须使用裸金属支架时，它们仍然不可或缺。

临床证据、更严格的监管以及以价值为导向的采购政策如何重塑相关人员对裸金属支架的产品策略和竞争差异化。

裸金属支架领域正经历一场变革，临床、技术和政策因素的综合作用正在重新定义其竞争定位和产品研发重点。在临床方面，基于现有证据，患者选择标准日趋精准，这些证据表明裸金属支架或其他支架材料哪种更有益，从而推动了针对特定适应症的器械设计的重新评估。在技​​术方面，合金成分、支架结构和输送系统的渐进式创新正在改善输送效果并减少急性血管损伤，进而影响临床医生的选择和手术流程。

2025 年美国关税措施的营运和战略影响迫使整个设备生态系统进行供应链重组、采购多元化和采购优先顺序的重新调整。

2025年美国关税政策的变化为跨境采购心血管器材的製造商、经销商和医疗保健系统带来了独特的营运和策略考量。各机构重新评估了其供应商组合，以控制总成本并降低关税波动带来的风险，这直接影响了供应链设计和采购决策。这种重组促使企业采取了一系列短期措施，包括製造地多元化、增加区域库存缓衝以及加快对具备相容品质系统的替代供应商进行认证。

详细的細項分析揭示了设备类型、材料成分、解剖适应性、临床环境和支架长度如何共同推动差异化的临床和商业策略。

关键的细分市场洞察揭示了裸金属支架领域内需求驱动因素和临床决策的多样性，为产品定位和临床互动策略提供了系统性的基础。无论器械类型如何，球囊扩张型和自扩张式平台之间的区别仍然是手术选择的核心。球囊扩张型系统更适合在冠状动脉环境中进行精准部署，而自扩张式设计则在扭转性血管和周边血管中表现优异，因为在这些血管中，持续的向外力和适应性至关重要。这种差异会影响研发优先顺序和销售培训，因为临床团队对部署机制和病变特异性治疗效果的重点各不相同。

美洲、欧洲、中东和非洲以及亚太地区管理体制、采购重点和临床基础设施的差异，决定了商业化和进入策略的差异化。

区域分析揭示了美洲、欧洲、中东和非洲以及亚太地区在需求模式、法规环境和医疗保健系统优先事项方面的差异，这些差异影响着产品引进和商业化策略。在美洲，医疗保健系统优先考虑以结果主导的采购，并日益关注能够维持临床品质的成本效益解决方案。在此背景下，基于证据的产品声明具有优势，并且强调伙伴关係模式，包括培训和结果报告，以在不同的医院系统中展示产品价值。特定国家的报销机制和集中筹资策略进一步影响医疗设备部署的速度和范围，因此需要製定细緻的市场进入计画。

竞争对手的发展趋势是由卓越的产品设计、有针对性的临床证据收集以及战略伙伴关係关係所驱动的，这些合作伙伴关係将产品范围从硬体扩展到整合服务解决方案。

裸金属支架市场的竞争格局既有成熟的医疗设备製造商，也有专注于渐进式创新、临床证据累积和策略伙伴关係的专业公司。主要企业正致力于研发耐用的产品设计、完善的医生培训项目以及健全的上市后监测倡议，以维持临床医生的信心并巩固基于大规模采购的合作关係。这些公司通常会利用现有的临床数据集和多中心註册研究来展示其产品在不同病变类型和患者亚群的表现。

为了确保成功推广并保持竞争优势，製造商必须协调临床证据、产品工程和敏捷的供应链——这是一个可行的策略挑战。

产业领导企业应采取多管齐下的策略，将产品创新、临床证据的累积以及商业性可行的供应链设计结合在一起。首先，他们可以透过优先进行专注于特定适应症疗效的临床试验和註册研究（特别是冠状动脉亚型，例如心肌梗塞和稳定性心绞痛，以及週边血管区域，例如俯卧位动脉和股腘动脉），来建立与介入医师和保险公司之间的差异化信誉。这些实证研究必须旨在解答临床医师面临的特定手术问题，并与医疗保健系统对疗效和成本效益报告的要求紧密契合。

严谨的混合方法研究框架，结合临床文献综述、监管分析和专家访谈，为决策者提供检验且可操作的综合见解。

本研究采用多方面方法，结合了对同侪审查的临床文献的系统性回顾、对监管相关公共记录的分析，以及对关键意见领袖（KOL）、采购专家和供应链高管的定性访谈。关键的定性研究结果与器械层面的性能数据和材料科学文献相结合，建构了关于临床效用、设计权衡和应用现状的全面视图。辅助资讯包括临床指南、手术登记册和公开的监管文件，并对其进行交叉引用，以检验医疗设备的分类和使用趋势。

总之，综合分析强调了裸金属支架的持久临床意义，以及在不断变化的临床、监管和政策压力下，维持其应用所需的策略重点。

总之，裸金属支架在血管介入治疗领域仍占据着重要的战略地位，其特征是临床适应症较为特殊、材料和设计方面存在权衡取舍，以及采购趋势日益复杂。儘管其他支架的出现拓展了治疗选择，但当病变特征、抗凝血治疗需求或入路限制等因素使其成为最佳选择时，裸金属支架仍然具有显着的临床和经济价值。在此背景下，成功应用裸金属支架需要采取协作方式，整合针对性的临床证据、设计优化和供应链韧性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：裸金属支架市场：依类型划分

  • 球囊扩张型
  • 自膨胀

第九章：裸金属支架市场：依材料划分

  • 钴铬合金
  • 不銹钢

第十章：裸金属支架市场（按长度划分）

  • 15～30
  • 30岁或以上
  • 15岁以下

第十一章：裸金属支架市场：依应用领域划分

  • 心血管系统
    • 冠状动脉
      • 心肌梗塞
      • 稳定性心绞痛
    • 结构性心臟疾病
  • 週边血管
    • 膝盖以下
    • 股腘窝

第十二章：裸金属支架市场：依最终用户划分

  • 门诊手术中心
  • 医院
    • 二级医疗保健
    • 三级医疗保健
  • 专科诊所
    • 心臟中心
    • 放射中心

第十三章：裸金属支架市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：裸金属支架市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：裸金属支架市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国裸金属支架市场

第十七章：中国裸金属帐篷市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abott Laboratories
  • ACE CARDIOPATHY
  • B. Braun SE
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Medtronic PLC
  • MeKo Manufacturing eK
  • Meril Life Sciences Pvt Ltd.
  • MicroPort Scientific Corporation
  • Relisys Medical Devices Limited
  • SLTL Group
  • STENTYS SA
  • Stryker Corporation
  • Terumo Corporation
  • Translumina Therapeutics
Product Code: MRR-CD5A9334DAB9

The Bare-metal Stents Market was valued at USD 6.96 billion in 2025 and is projected to grow to USD 7.33 billion in 2026, with a CAGR of 5.84%, reaching USD 10.37 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.96 billion
Estimated Year [2026] USD 7.33 billion
Forecast Year [2032] USD 10.37 billion
CAGR (%) 5.84%

An authoritative orientation to bare-metal stents that clarifies their clinical role, material evolution, and procedural relevance within contemporary interventional practice

The bare-metal stent landscape represents a foundational element of interventional vascular care, where device selection, procedural practice, and material science converge to affect patient outcomes. This introduction frames the current technological and clinical backdrop, situating bare-metal stents within their enduring role for specific patient cohorts and procedural contexts. While drug-eluting platforms and bioresorbable scaffolds have reshaped choices for many clinicians, bare-metal devices remain integral where specific lesion characteristics, anticoagulation considerations, or cost and access constraints dictate their use.

In discussing the device class, it is important to highlight advances in radial strength, strut geometry, and delivery system ergonomics that continue to refine procedural success and reduce complication rates. Parallel progress in imaging, such as intravascular ultrasound and optical coherence tomography, enhances lesion assessment and device placement precision, thereby increasing the clinical value delivered by contemporary bare-metal stents. Moreover, material improvements in cobalt chromium and stainless steel alloys have created a spectrum of options that balance visibility, flexibility, and chronic vessel interaction.

Regulatory pathways and clinical evidence generation remain crucial drivers of adoption, with randomized studies and registries informing guidelines and reimbursement decisions. The intersection of clinical need, device evolution, and health system economics sets the stage for stakeholders to make evidence-based decisions. This report opens by establishing these core themes and prepares readers for a deeper analysis of market dynamics, policy impacts, segmentation insights, and regional variations that collectively shape strategic imperatives for manufacturers, clinicians, and payers.

How converging clinical evidence, regulatory stringency, and value-driven procurement are reshaping product strategies and competitive differentiation for bare-metal stent stakeholders

The bare-metal stent domain is undergoing transformative shifts driven by converging clinical, technological, and policy forces that are redefining competitive positioning and product development priorities. Clinically, patient selection is becoming more nuanced as evidence distinguishes subpopulations that benefit from bare-metal solutions versus alternative scaffolds, prompting a recalibration of indication-specific device design. Technologically, incremental innovations in alloy formulation, strut architecture, and delivery system refinement are enabling improved deliverability and reduced acute vessel trauma, which in turn inform clinician preference and procedural workflow.

Simultaneously, health systems are intensifying scrutiny of total procedural value, factoring in device cost, hospitalization duration, and post-procedural care needs. As a result, procurement decisions are increasingly influenced by comparative performance metrics and real-world evidence rather than price alone. Regulatory landscapes are evolving as well, with more rigorous post-market surveillance expectations and demand for longitudinal safety data that can alter life-cycle management strategies for existing platforms. These regulatory dynamics incentivize manufacturers to invest in extended follow-up studies and registry partnerships to sustain clinician and payer confidence.

Innovation ecosystems are further shaped by the integration of digital health tools, such as procedural analytics and remote follow-up platforms, that extend the value proposition of device manufacturers beyond hardware. Collaborations between device firms and service providers are emerging to bundle devices with analytics, training, and outcomes reporting, creating differentiated offerings that address both clinical and economic stakeholder needs. Together, these shifts underscore a market in which incremental technical advances intersect with broader system-level priorities, compelling firms to adopt a more holistic, evidence-driven approach to product strategy and commercialization.

Operational and strategic consequences of U.S. tariff measures in 2025 that compelled supply chain reconfiguration, sourcing diversification, and procurement reprioritization across the device ecosystem

Tariff policy changes in the United States during 2025 introduced a distinct set of operational and strategic considerations for manufacturers, distributors, and health systems that engage in cross-border procurement of cardiovascular devices. Supply chain design and sourcing decisions were directly affected as organizations re-evaluated supplier portfolios to manage landed costs and mitigate exposure to tariff volatility. This realignment prompted near-term shifts toward diversifying manufacturing footprints, increasing regional inventory buffers, and accelerating qualification of alternative suppliers with compatible quality systems.

Procurement teams reacted by intensifying contract negotiations, seeking longer-term agreements that could stabilize inbound pricing and reduce transactional uncertainty. At the same time, some firms revisited their value engineering initiatives to offset cost impacts without compromising clinical performance, focusing on material selection, manufacturing efficiencies, and packaging optimization. For device companies with vertically integrated production, accelerated capital allocation toward domestic or tariff-exempt manufacturing nodes became a tactical lever to preserve market access and protect margins.

Clinically, hospitals and ambulatory surgical centers confronted procurement trade-offs where device selection decisions had to balance immediate budgetary constraints against longer-term clinical outcomes and reintervention risks. The tariff environment also influenced investor sentiment and strategic partnerships, with cross-border joint ventures and licensing arrangements emerging as mechanisms to maintain market presence while sharing the burden of localized manufacturing and regulatory compliance. Collectively, these dynamics emphasize the importance of flexible supply chain strategies, proactive regulatory planning, and commercially defensible pricing models in a landscape altered by tariff interventions.

Deep segmentation analysis revealing how device type, material composition, anatomical application, clinical setting, and stent length combine to drive differentiated clinical and commercial strategies

Key segmentation insights illuminate the heterogeneity of demand drivers and clinical decision-making within the bare-metal stent category, providing a structured basis for product positioning and clinical engagement strategies. Across device type, the dichotomy between balloon expandable and self-expanding platforms remains central to procedural selection, with balloon expandable systems favored for precise deployment in coronary settings and self-expanding designs offering advantages in tortuous or peripheral vessels where chronic outward force and conformability are paramount. This distinction influences R&D prioritization and sales training as different clinical teams emphasize deployment mechanics and lesion-specific outcomes.

Material segmentation further differentiates product attributes, with cobalt chromium alloys offering superior radial strength and radiopacity relative to stainless steel, which in turn yields trade-offs in flexibility and cost. Product teams must therefore align material choices to targeted lesion subsets and clinician preferences, ensuring that bench performance translates into predictable clinical behavior. Application-based segmentation clarifies end-use contexts: cardiovascular applications encompass coronary and structural heart interventions, where the coronary subdomain addresses acute conditions such as myocardial infarction and stable angina with distinct procedural imperatives, while peripheral vascular use includes below-the-knee and femoropopliteal territories that present unique lesion morphology and durability considerations. These clinical nuances necessitate tailored evidence packages and targeted physician education that speak directly to differential outcomes across anatomical locations.

End-user segmentation highlights variations across ambulatory surgical centers, hospitals, and specialty clinics. Hospitals bifurcate into secondary care and tertiary care settings, each with different case mixes, procurement processes, and clinical governance that influence device adoption timelines. Specialty clinics such as dedicated cardiac centers and radiology centers require customized supply relationships and training models to integrate devices into their specific workflows. Length-based segmentation-devices designed for lengths less than 15 millimeters, within a 15 to 30 millimeter range, or greater than 30 millimeters-further refines product portfolios, as lesion length correlates with procedural complexity, overlap strategies, and adjunctive therapy choices. Synthesizing these segmentation layers enables commercial teams to position product variants with precision, tailor clinical evidence generation, and design pricing strategies that reflect clinical utility and procedural economics.

How contrasting regulatory regimes, procurement priorities, and clinical infrastructure across the Americas, Europe Middle East & Africa, and Asia-Pacific dictate differentiated commercialization and access strategies

Regional insights reveal divergent demand patterns, regulatory environments, and health system priorities that shape adoption and commercialization approaches across the Americas, Europe, Middle East & Africa, and Asia-Pacific territories. In the Americas, health systems emphasize outcome-driven procurement with an increasing focus on cost-effective solutions that preserve clinical quality; this context favors evidence-backed product claims and emphasizes partnership models that include training and outcomes reporting to demonstrate value across diverse hospital systems. Reimbursement mechanisms and centralized procurement strategies in certain countries further influence the pace and scope of device uptake, requiring nuanced market access planning.

Across Europe, the Middle East and Africa, regulatory harmonization efforts and localized health economics assessments create a layered commercialization landscape. Countries within this region vary widely in their procedural volumes, infrastructure maturity, and reimbursement frameworks, which necessitates flexible go-to-market models that can be adapted to both high-acuity tertiary centers and emerging secondary care facilities. In many markets, clinician networks and regional opinion leaders play an outsized role in adoption, making targeted clinical partnerships and registry participation critical.

The Asia-Pacific region exhibits dynamic growth in interventional capacity, with a broad spectrum of clinical settings from high-volume centers in advanced economies to rapidly developing hospital infrastructures elsewhere. Supply chain logistics, tariff considerations, and local manufacturing partnerships are particularly salient here, as device accessibility often depends on regulatory alignment and strategic in-region production. Across all regions, tailoring clinical evidence, training programs, and commercial propositions to the specific procurement drivers and care delivery models is essential to unlocking sustainable adoption and building long-term clinician trust.

Competitive dynamics driven by product engineering excellence, targeted clinical evidence collection, and strategic partnerships that extend offerings beyond hardware into integrated service solutions

The competitive landscape for bare-metal stents is characterized by a mix of established medical device firms and specialized companies that prioritize incremental innovation, clinical evidence generation, and strategic partnerships. Leading organizations invest in durable product engineering, comprehensive physician training programs, and robust post-market surveillance initiatives to maintain clinician confidence and support volume-based procurement relationships. These firms often leverage legacy clinical datasets and multi-center registries to demonstrate device performance across varied lesion types and patient subgroups.

At the same time, smaller and mid-sized companies focus on niche differentiation through novel alloy formulations, unique strut designs, or specialized delivery systems that address specific anatomical challenges or procedural workflows. Collaboration between such innovators and larger distributors or contract manufacturers accelerates market entry while mitigating scale-related constraints. Partnerships with clinical investigators and hospital networks enable rapid collection of real-world evidence that can substantiate claims and inform iterative design improvements.

Strategic alliances extend beyond product development, encompassing logistics providers, analytics vendors, and training organizations to create integrated offerings that extend the value proposition to hospitals and clinics. Companies that align research priorities with payer evidence requirements and procedural economics are better positioned to influence procurement decisions. Overall, competitive success hinges on a combination of engineering excellence, evidence-based engagement, and flexible commercial models that respond to evolving clinician and health system expectations.

Actionable strategic imperatives for manufacturers to align clinical evidence, product engineering, and agile supply chains to secure adoption and sustain competitive advantage

Industry leaders should adopt a multi-dimensional strategy that aligns product innovation with clinical evidence generation and commercially pragmatic supply chain design. First, prioritizing targeted clinical studies and registries that address indication-specific performance-particularly in coronary subsets such as myocardial infarction and stable angina as well as peripheral territories like below-the-knee and femoropopliteal-will create differentiated credibility among interventionists and payers. These evidence efforts should be designed to answer the specific procedural questions that clinicians face, and to dovetail with health system requirements for outcomes and cost-effectiveness reporting.

Second, manufacturers should pursue material and design investments that map to clear clinical advantages; for example, alloy selection between cobalt chromium and stainless steel should be justified by demonstrable benefits in deliverability, radiopacity, or strut performance for the targeted lesion set. Concurrently, modular product portfolios organized by stent length categories and deployment mechanism-balloon expandable versus self-expanding-enable more precise matching of device attributes to lesion morphology, reducing off-label use and optimizing clinical outcomes.

Third, rethinking supply chain architecture to incorporate regional manufacturing, inventory flexibility, and tariff-aware sourcing will mitigate geopolitical and policy risks. Complementary commercial initiatives should bundle training, procedural analytics, and post-market surveillance to create a total product offering valued by hospitals and specialty clinics. Finally, adopt flexible pricing and contracting models that reflect the procurement realities of ambulatory surgical centers, secondary and tertiary hospitals, and specialty clinics, thereby improving access while protecting margin and supporting sustained innovation.

A rigorous mixed-method research framework combining clinical literature review, regulatory analysis, and expert interviews to produce a validated and actionable synthesis for decision-makers

This research employed a multi-method approach combining systematic review of peer-reviewed clinical literature, analysis of regulatory public records, and qualitative interviews with key opinion leaders, procurement specialists, and supply chain executives. Primary qualitative insights were synthesized with device-level performance data and material science literature to create an integrated view of clinical utility, design trade-offs, and deployment contexts. Secondary sources included clinical guidelines, procedural registries, and publicly available regulatory documents, which were cross-referenced to validate device classifications and usage trends.

Interview subjects were selected to represent a balanced cross-section of interventionists, hospital procurement leaders, and device development professionals across varied geographies and clinical settings. The synthesis prioritized triangulation of findings, aligning clinician perspectives with documented outcomes and regulatory milestones to reduce bias and improve applicability. Methodological rigor was maintained through transparent documentation of inclusion criteria, source provenance, and the analytical framework used to map segmentation, regional dynamics, and competitive positioning.

Limitations inherent to this approach include variability in reporting standards across registries, differential availability of long-term post-market data, and rapid evolution in device development that may outpace published literature. To mitigate these constraints, the research emphasizes evidence-weighting and signals derived from recent high-quality sources and expert consensus, while recommending ongoing surveillance of emerging data to refine strategic decisions.

Concluding synthesis emphasizing the enduring clinical relevance of bare-metal stents and the strategic priorities required to maintain adoption amid evolving clinical, regulatory, and policy pressures

In conclusion, the bare-metal stent domain remains strategically important within interventional vascular care, defined by nuanced clinical indications, material and design trade-offs, and increasingly sophisticated procurement dynamics. While alternative scaffolds have expanded therapeutic options, bare-metal devices continue to offer distinct clinical and economic value where lesion characteristics, anticoagulation needs, or access constraints make them the preferred choice. Success in this landscape requires a coordinated approach that integrates targeted clinical evidence, design optimization, and supply chain resilience.

Manufacturers and stakeholders that align product portfolios to clinically meaningful segmentation-encompassing device type, material composition, application area, end-user context, and stent length-will be best positioned to address clinician needs and procurement realities. Regional strategies must be adapted to local regulatory frameworks and health system priorities, with particular attention to the differing dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific. Finally, tariff and policy fluctuations underscore the imperative for flexible sourcing strategies and collaborative relationships with health systems to maintain stable access.

These conclusions point toward practical next steps: invest in indication-specific evidence generation, refine material and design choices based on clinical needs, and build commercialization models that pair devices with services and data to demonstrate tangible procedural and economic value. Executed well, these measures will enable stakeholders to navigate evolving clinical expectations and policy environments while maintaining the clinical relevance of bare-metal stent platforms.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bare-metal Stents Market, by Type

  • 8.1. Balloon Expandable
  • 8.2. Self Expanding

9. Bare-metal Stents Market, by Material

  • 9.1. Cobalt Chromium
  • 9.2. Stainless Steel

10. Bare-metal Stents Market, by Length

  • 10.1. 15 to 30
  • 10.2. Greater Than 30
  • 10.3. Less Than 15

11. Bare-metal Stents Market, by Application

  • 11.1. Cardiovascular
    • 11.1.1. Coronary
      • 11.1.1.1. Myocardial Infarction
      • 11.1.1.2. Stable Angina
    • 11.1.2. Structural Heart
  • 11.2. Peripheral Vascular
    • 11.2.1. Below The Knee
    • 11.2.2. Femoropopliteal

12. Bare-metal Stents Market, by End User

  • 12.1. Ambulatory Surgical Center
  • 12.2. Hospital
    • 12.2.1. Secondary Care
    • 12.2.2. Tertiary Care
  • 12.3. Specialty Clinic
    • 12.3.1. Cardiac Center
    • 12.3.2. Radiology Center

13. Bare-metal Stents Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bare-metal Stents Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bare-metal Stents Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Bare-metal Stents Market

17. China Bare-metal Stents Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abott Laboratories
  • 18.6. ACE CARDIOPATHY
  • 18.7. B. Braun SE
  • 18.8. Becton, Dickinson and Company
  • 18.9. BIOTRONIK SE & Co. KG
  • 18.10. Boston Scientific Corporation
  • 18.11. Cook Group Incorporated
  • 18.12. Medtronic PLC
  • 18.13. MeKo Manufacturing e.K.
  • 18.14. Meril Life Sciences Pvt Ltd.
  • 18.15. MicroPort Scientific Corporation
  • 18.16. Relisys Medical Devices Limited
  • 18.17. SLTL Group
  • 18.18. STENTYS SA
  • 18.19. Stryker Corporation
  • 18.20. Terumo Corporation
  • 18.21. Translumina Therapeutics

LIST OF FIGURES

  • FIGURE 1. GLOBAL BARE-METAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BARE-METAL STENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BARE-METAL STENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BARE-METAL STENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BARE-METAL STENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BARE-METAL STENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BARE-METAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BARE-METAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BARE-METAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SELF EXPANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SELF EXPANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SELF EXPANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BARE-METAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BARE-METAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BARE-METAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BARE-METAL STENTS MARKET SIZE, BY 15 TO 30, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BARE-METAL STENTS MARKET SIZE, BY 15 TO 30, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BARE-METAL STENTS MARKET SIZE, BY 15 TO 30, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BARE-METAL STENTS MARKET SIZE, BY GREATER THAN 30, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BARE-METAL STENTS MARKET SIZE, BY GREATER THAN 30, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BARE-METAL STENTS MARKET SIZE, BY GREATER THAN 30, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LESS THAN 15, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LESS THAN 15, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BARE-METAL STENTS MARKET SIZE, BY LESS THAN 15, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BARE-METAL STENTS MARKET SIZE, BY MYOCARDIAL INFARCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STABLE ANGINA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STABLE ANGINA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STRUCTURAL HEART, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STRUCTURAL HEART, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BARE-METAL STENTS MARKET SIZE, BY STRUCTURAL HEART, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BELOW THE KNEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BELOW THE KNEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BARE-METAL STENTS MARKET SIZE, BY BELOW THE KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BARE-METAL STENTS MARKET SIZE, BY FEMOROPOPLITEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BARE-METAL STENTS MARKET SIZE, BY FEMOROPOPLITEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BARE-METAL STENTS MARKET SIZE, BY FEMOROPOPLITEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BARE-METAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BARE-METAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BARE-METAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SECONDARY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SECONDARY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SECONDARY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BARE-METAL STENTS MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIAC CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIAC CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BARE-METAL STENTS MARKET SIZE, BY CARDIAC CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BARE-METAL STENTS MARKET SIZE, BY RADIOLOGY CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BARE-METAL STENTS MARKET SIZE, BY RADIOLOGY CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BARE-METAL STENTS MARKET SIZE, BY RADIOLOGY CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BARE-METAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS BARE-METAL STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL BARE-METAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GCC BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. GCC BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 183. GCC BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. GCC BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 185. GCC BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 186. GCC BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 187. GCC BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. GCC BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 189. GCC BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 212. G7 BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. G7 BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 215. G7 BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 216. G7 BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. G7 BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 218. G7 BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 219. G7 BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 220. G7 BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. G7 BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 222. G7 BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 223. NATO BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. NATO BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. NATO BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 226. NATO BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 227. NATO BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. NATO BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 229. NATO BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 230. NATO BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 231. NATO BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. NATO BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 233. NATO BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL BARE-METAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES BARE-METAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA BARE-METAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA BARE-METAL STENTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA BARE-METAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA BARE-METAL STENTS MARKET SIZE, BY LENGTH, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA BARE-METAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA BARE-METAL STENTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA BARE-METAL STENTS MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA BARE-METAL STENTS MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA BARE-METAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA BARE-METAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA BARE-METAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, 2018-2032 (USD MILLION)